• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    OmniAb, Inc. - Common Stock (NQ: OABI )

    4.800 +0.100 (+2.13%)
    Streaming Delayed Price Updated: 11:16 AM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about OmniAb, Inc. - Common Stock

    < Previous 1 2 Next >
    OABI Stock Earnings: OmniAb Misses EPS, Misses Revenue for Q1 2024
    OABI stock results show that OmniAb missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying
    Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
    Via Benzinga
    OABI Stock Earnings: OmniAb Beats EPS, Misses Revenue for Q4 2023
    OABI stock results show that OmniAb beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    Recap: OmniAb Q4 Earnings
    Via Benzinga
    Earnings Scheduled For March 20, 2024
    Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million. 
    Via Benzinga
    Earnings Preview For OmniAb
    Via Benzinga
    Mighty Minis: 7 Small-Cap Stocks That Punch Above Their Weight
    While you can likely achieve a higher degree of success with blue chips, for blistering gains, turn to powerful small-cap stocks. 
    Via InvestorPlace
    7 of the Best Cheap Stocks to Buy Under $5 in October 2023
    While the concept is incredibly risky, those who want to give their portfolio a jolt should consider these best cheap stocks. 
    Via InvestorPlace
    Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    7 Stocks to Buy for 200% Returns This Year
    These high return stock investments all have the potential to triple in 2023 based on Wall Street expectations. 
    Via InvestorPlace
    Earnings Scheduled For August 10, 2023
    Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million. 
    Via Benzinga
    7 Stocks to Buy for Their Massive Upside Potential
    While blue chips are relatively predictable, they’re also boring. For serious gains, you need to check out these stocks to buy now. 
    Via InvestorPlace
    Stratasys, Navitas Semiconductor, United Insurance And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks traded mostly lower, with the Dow Jones dropping around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    $1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed higher on Monday after recording losses last week. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
    Via Benzinga
    7 Biotech Stocks With Huge Return Potential for Long-Term Investors
    Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2023
    Via Benzinga
    Earnings Scheduled For March 30, 2023
    Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million. 
    Via Benzinga
    7 Biotech Stocks That Could Be the Next Big Thing
    Although speculation might be a tough call at this juncture, these biotech stocks and their underlying science might be compelling enough. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
    Via Benzinga
    Some 'Transgenic Animal Platforms Are More Than Equal,' Analyst Initiating Coverage On OmniAb Says
    Credit Suisse initiated coverage on OmniAb Inc (NASDAQ: OABI) with an Outperform rating and a price target of $13. 
    Via Benzinga
    $1 Million Bet On OmniAb? Check Out These 3 Penny Stocks Insiders Are Buying
    The Dow Jones closed lower by around 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 20, 2022
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
    Via Benzinga
    Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
    Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
    Via Benzinga
    Nasdaq Down 60 Points; Alibaba Posts Upbeat Q2 Earnings
    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 60 points on Thursday. 
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.